Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Grapefruit juice prolongs the QT interval of healthy volunteers and patients with long QT syndrome.

Chorin E, Hochstadt A, Granot Y, Khoury S, Schwartz AL, Margolis G, Barashi R, Viskin D, Ghantous E, Schnapper M, Mekori T, Fourey D, Guevara-Valdivia ME, Marquez MF, Zeltzer D, Rosso R, Viskin S.

Heart Rhythm. 2019 May 8. pii: S1547-5271(19)30368-6. doi: 10.1016/j.hrthm.2019.04.039. [Epub ahead of print]

PMID:
31075442
2.

Grapefruit-medication interactions: forbidden fruit or avoidable consequences?

Bailey DG, Dresser G, Arnold JM.

CMAJ. 2013 Mar 5;185(4):309-16. doi: 10.1503/cmaj.120951. Epub 2012 Nov 26. Review. No abstract available.

3.

Towards safer and more predictable drug treatment--reflections from studies of the First BCPT Prize awardee.

Neuvonen PJ.

Basic Clin Pharmacol Toxicol. 2012 Mar;110(3):207-18. doi: 10.1111/j.1742-7843.2012.00858.x. Review.

4.

A dangerous fruit juice.

Agosti S, Casalino L, Bertero G, Barsotti A, Brunelli C, Morelloni S.

Am J Emerg Med. 2012 Jan;30(1):248.e5-8. doi: 10.1016/j.ajem.2010.08.031. Epub 2010 Oct 20.

PMID:
20970282
5.

Effects of pink grapefruit juice on QT variability in patients with dilated or hypertensive cardiomyopathy and in healthy subjects.

Piccirillo G, Magrì D, Matera S, Magnanti M, Pasquazzi E, Schifano E, Velitti S, Mitra M, Marigliano V, Paroli M, Ghiselli A.

Transl Res. 2008 May;151(5):267-72. doi: 10.1016/j.trsl.2008.03.002. Epub 2008 Apr 9.

PMID:
18433709
6.

The additive effects of the active component of grapefruit juice (naringenin) and antiarrhythmic drugs on HERG inhibition.

Lin C, Ke X, Ranade V, Somberg J.

Cardiology. 2008;110(3):145-52. Epub 2007 Dec 4.

PMID:
18057881
7.

Desloratadine: an update of its efficacy in the management of allergic disorders.

Murdoch D, Goa KL, Keam SJ.

Drugs. 2003;63(19):2051-77. Review.

PMID:
12962522
8.

Inhibition of cytochrome P450 3A: relevant drug interactions in gastroenterology.

Sagir A, Schmitt M, Dilger K, Häussinger D.

Digestion. 2003;68(1):41-8. Epub 2003 Aug 29. Review.

PMID:
12949438
9.

Grapefruit and tonic: a deadly combination in a patient with the long QT syndrome.

Hermans K, Stockman D, Van den Branden F.

Am J Med. 2003 Apr 15;114(6):511-2. No abstract available.

PMID:
12727589
10.

Pharmacokinetic and pharmacodynamic interaction between grapefruit juice and halofantrine.

Charbit B, Becquemont L, Lepère B, Peytavin G, Funck-Brentano C.

Clin Pharmacol Ther. 2002 Nov;72(5):514-23.

PMID:
12426515
11.

The pharmacologic profile of desloratadine: a review.

Henz BM.

Allergy. 2001;56 Suppl 65:7-13. Review.

PMID:
11243504
12.
13.

Drug interactions with cisapride: clinical implications.

Michalets EL, Williams CR.

Clin Pharmacokinet. 2000 Jul;39(1):49-75. Review.

PMID:
10926350
14.

[Projection of new antihistamines].

Eseverri J.

Allergol Immunopathol (Madr). 2000 May-Jun;28(3):143-52. Review. Spanish.

PMID:
10867385
15.

Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.

Dresser GK, Spence JD, Bailey DG.

Clin Pharmacokinet. 2000 Jan;38(1):41-57. Review.

PMID:
10668858
16.

Drug interactions with grapefruit: whose responsibility is it to warn the public?

Spence JD.

Clin Pharmacol Ther. 1997 Apr;61(4):395-400. No abstract available.

PMID:
9129556
17.

The cardiac effects of terfenadine after inhibition of its metabolism by grapefruit juice.

Clifford CP, Adams DA, Murray S, Taylor GW, Wilkins MR, Boobis AR, Davies DS.

Eur J Clin Pharmacol. 1997;52(4):311-5.

PMID:
9248771
18.

Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers.

Min DI, Ku YM, Geraets DR, Lee H.

J Clin Pharmacol. 1996 May;36(5):469-76.

PMID:
8739026
19.

Grapefruit juice alters the systemic bioavailability and cardiac repolarization of terfenadine in poor metabolizers of terfenadine.

Honig PK, Wortham DC, Lazarev A, Cantilena LR.

J Clin Pharmacol. 1996 Apr;36(4):345-51.

PMID:
8728348
20.

Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram.

Benton RE, Honig PK, Zamani K, Cantilena LR, Woosley RL.

Clin Pharmacol Ther. 1996 Apr;59(4):383-8.

PMID:
8612381

Supplemental Content

Loading ...
Support Center